Global Conference 2026

Financing R&D in an Era of Strategic Realignment (Invite only)

-
REQUEST INVITE

The pace and complexity of today’s scientific opportunities demand financing models that are more collaborative and resilient than those that depend primarily on government funding. As demand for research talent grows, science R&D is being reshaped by new actors, new incentives, and new capital structures. How can public- and private-sector partners build financing models that keep high-impact R&D moving from early-stage discovery to translation and adoption? What partnerships, pooled vehicles, and incentive structures can support young scientists, sustain research capacity, and turn breakthroughs into real impact worldwide?

    Speakers

    Image

    Iain Foulkes

    Executive Director, Research and Innovation, Cancer Research UK; CEO, Cancer Research Horizons
    DR

    David Reese

    Executive Vice President and Chief Technology Officer, Amgen
    Image

    Lisa Suennen

    Managing Partner, American Heart Association Ventures